(Q24246031)

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

Ketorolac for sickle cell vaso-occlusive crisis pain in the emergency department: lack of a narcotic-sparing effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

Judging the effectiveness of analgesia for children and adolescents during vaso-occlusive events of sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

Transdermal fentanyl administration in children and adolescents with sickle cell pain crisis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

Acupuncture: An evaluation in the painful crises of sickle cell anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

Medroxyprogesterone acetate and homozygous sickle-cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

An open comparative study of dispersible piroxicam versus soluble acetylsalicylic acid for the treatment of osteoarticular painful attack during sickle cell crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

Oral analgesia for treatment of painful crisis in sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

A trial of folate supplementation in children with homozygous sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

The painful crisis of homozygous sickle cell disease: clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

Patient-controlled analgesia for sickle-cell-related pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

Sickle cell disease: clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

Plasma levels and analgesia following deltoid and gluteal injections of methadone and morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

Clinical management of acute pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

Clinical trials of therapy for sickle cell vaso-occlusive crises. Cooperative urea trials group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

7 January 2021

Steady-state kinetics and analgesic effect of oral morphine in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

7 January 2021

The use of patient-controlled analgesia in adolescents with sickle cell pain crisis: a preliminary report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

7 January 2021

Intravenous morphine pharmacokinetics in pediatric patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

7 January 2021

Randomised trial of oral morphine for painful episodes of sickle-cell disease in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

7 January 2021

Meperidine usage in patients with sickle cell crisis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

7 January 2021

Management of sickle cell pain crisis in the emergency department at teaching hospitals

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

7 January 2021

Pain in sickle cell disease. Rates and risk factors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

7 January 2021

High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

7 January 2021

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

7 January 2021

The anaesthetist's role in acute sickle cell crisis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

7 January 2021

Patient-controlled analgesia in patients with sickle cell vaso-occlusive crisis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

7 January 2021

Acute admissions of patients with sickle cell disease who live in Britain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

7 January 2021

Transcutaneous electrical nerve stimulation treatment of sickle cell pain crises

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

7 January 2021

Treatment of sickle cell diseases with aspirin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

7 January 2021

Treatment of painful sickle cell crises: assessment of new methods

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

7 January 2021

Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

7 January 2021

Treating sickle cell pain like cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003350.PUB2

7 January 2021

Pain and pain control in children

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD003350.PUB2

Pain intensity and home pain management of children with sickle cell disease.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD003350.PUB2

[Home care of vaso-occlusive crisis in sickle cell disease in Togo]

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD003350.PUB2

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD003350.PUB2

Identifiers

DOI

10.1002/14651858.CD003350.PUB2

1 reference

Consolidated OpenCitations Corpus – April 2017

905356

905356

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference